What is NDC 42806-271?

42806-271 is the product NDC for Cholestyramine Light, Cholestyramine 4 g/5.7g powder, for suspension, listed with the FDA by EPIC PHARMA, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

EPIC PHARMA, LLC, NDC labeler code 42806. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cholestyramine Light?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cholestyramine Light NDC 42806-271

NDC codes

FDA NDC Directory

Product NDC (as listed)42806-271Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42806-0271Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42806-271-93	4280602719342806027193	239.6 g in 1 JAR (42806-271-93)Marketed from Sep 29, 2023
42806-271-97	4280602719742806027197	239.6 g in 1 CAN (42806-271-97)Marketed from Dec 15, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cholestyramine Light
Generic name (nonproprietary): cholestyramine light
Active ingredients: Cholestyramine — 4 g/5.7g
Dosage form: Powder, For suspension
Route: Oral
Labeler: EPIC PHARMA, LLCNDC labeler code 42806
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074558
Marketing start: Dec 15, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Bile-acid Binding Activity (Mechanism)
Identifiers: Product ID 42806-271_f21139d8-d54b-4fbc-add3-aa4bcefb4e2cSPL ID f21139d8-d54b-4fbc-add3-aa4bcefb4e2cSPL set ID f8740b85-75f9-4e00-a8d3-7175298f1724RxCUI 1801279UNII 4B33BGI082
Pharmacologic class: Bile Acid Sequestrant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442806027193 followed by a unit qualifier and the quantity

Package 42806-0271-93. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 17, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE 1) Cholestyramine for Oral Suspension, USP Light powder is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Cholestyramine for Oral Suspension, USP Light powder may be useful to lower LDL cholesterol in patients who also have hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern. Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 42806-271

What is NDC 42806-271?: 42806-271 is the product NDC for Cholestyramine Light, Cholestyramine 4 g/5.7g powder, for suspension, listed with the FDA by EPIC PHARMA, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cholestyramine Light.
What is the active ingredient?: Cholestyramine.
Who is the labeler?: EPIC PHARMA, LLC, NDC labeler code 42806. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cholestyramine Light?: 5 other product NDCs are listed under this name. See all Cholestyramine Light NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cholestyramine Light NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cholestyramine Light	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-270	24658-0270-95
Cholestyramine Light	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-271	24658-0271-9324658-0271-97
Cholestyramine Light	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	EPIC PHARMA, LLC	42806-269	42806-0269-98
Cholestyramine Light	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	EPIC PHARMA, LLC	42806-270	42806-0270-95
Cholestyramine Lightcholestyramine	Cholestyramine 4 g/4.8g	Powder, For suspensionOral	TAGI Pharma, Inc.	51224-009	51224-0009-10

Other NDCs under ANDA 074558

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074558
Product	Strength	Form · route	Labeler	Product NDC
Cholestyramine Light	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-270
Cholestyramine Light	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-271
Cholestyramine Light	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	EPIC PHARMA, LLC	42806-269
Cholestyramine Light	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	EPIC PHARMA, LLC	42806-270